Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review
- PMID: 19231978
- DOI: 10.1086/597291
Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review
Abstract
A systematic review was performed to determine the effectiveness of different approaches for eradicating methicillin-resistant Staphylococcus aureus carriage. Twenty-three clinical trials were selected that evaluated oral antibiotics (7 trials), topically applied antibiotics (12 trials), or both (4 trials). Because of clinical heterogeneity, quantitative analysis of all studies was deemed to be inappropriate, and exploratory subgroup analyses were performed for studies with similar study populations, methods, and targeted bacteria. The estimated pooled relative risk of treatment failure 1 week after short-term nasal mupirocin treatment, compared with placebo, was 0.10 (range, 0.07-0.14). There was low heterogeneity between study outcomes, and effects were similar for patients and healthy subjects, as well as in studies that included only methicillin-susceptible S. aureus carriers or both methicillin-susceptible S. aureus and methicillin-resistant S. aureus carriers. The development of drug resistance during treatment was reported in 1% and 9% of patients receiving mupirocin and oral antibiotics, respectively. Short-term nasal application of mupirocin is the most effective treatment for eradicating methicillin-resistant S. aureus carriage, with an estimated success of rate of 90% 1 week after treatment and approximately 60% after a longer follow-up period.
Similar articles
-
Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.J Antimicrob Chemother. 2011 Oct;66(10):2418-24. doi: 10.1093/jac/dkr250. Epub 2011 Jun 30. J Antimicrob Chemother. 2011. PMID: 21719471
-
Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.J Antimicrob Chemother. 2011 Oct;66(10):2409-17. doi: 10.1093/jac/dkr243. Epub 2011 Jun 30. J Antimicrob Chemother. 2011. PMID: 21719473
-
Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.Am J Infect Control. 2007 Mar;35(2):106-14. doi: 10.1016/j.ajic.2006.09.005. Am J Infect Control. 2007. PMID: 17327190 Review.
-
Effectiveness of meticillin-resistant Staphylococcus aureus decolonization in long-term haemodialysis patients: a systematic review and meta-analysis.J Hosp Infect. 2015 Nov;91(3):250-6. doi: 10.1016/j.jhin.2015.08.015. Epub 2015 Aug 29. J Hosp Infect. 2015. PMID: 26443485 Review.
-
NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00502-17. doi: 10.1128/AAC.00502-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28607014 Free PMC article.
Cited by
-
Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?Infect Control Hosp Epidemiol. 2009 Dec;30(12):1158-65. doi: 10.1086/648087. Infect Control Hosp Epidemiol. 2009. PMID: 19852665 Free PMC article.
-
Risk factors for deep surgical site infections after spinal fusion.Eur Spine J. 2010 Oct;19(10):1711-9. doi: 10.1007/s00586-010-1421-y. Epub 2010 May 6. Eur Spine J. 2010. PMID: 20445999 Free PMC article. Clinical Trial.
-
Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancer.Pediatr Blood Cancer. 2010 Dec 15;55(7):1317-22. doi: 10.1002/pbc.22815. Epub 2010 Sep 9. Pediatr Blood Cancer. 2010. PMID: 20830777 Free PMC article.
-
In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.Antimicrob Agents Chemother. 2011 Sep;55(9):4416-9. doi: 10.1128/AAC.00217-11. Epub 2011 Jul 11. Antimicrob Agents Chemother. 2011. PMID: 21746950 Free PMC article.
-
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study.PLoS One. 2019 Mar 22;14(3):e0213497. doi: 10.1371/journal.pone.0213497. eCollection 2019. PLoS One. 2019. PMID: 30901344 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical